The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner BPC 157: Miracle Healing Peptide or Hidden Danger? FDA considers adding a dozen peptides to its bulk drug compounding list RAPS